Stoke Therapeutics, Inc. (STOK)
Across 28 earnings reports since Aug 14, 2019, Stoke Therapeutics, Inc. (STOK) has a clear post-earnings pattern. It moves ±9.05% on average after reporting and finishes higher 50.0% of the time. Its largest post-earnings gain was +58.31% (Mar 25, 2024) and its largest decline was -25.3% (Nov 14, 2022). The next earnings report is predicted for 2026-08-10 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
28
Avg Abs. Movement
±9.05%
Positive %
50.0%
Negative %
50.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 07, 2026 | ☽ POST | $32.66 | $32.82 | $32.80 | 27,470 | +0.4% | open_in_new |
| Jan 12, 2026 | ☀ PRE | $27.40 | $29.49 | $29.42 | 1,965,000 | -10.44% | open_in_new |
| Nov 04, 2025 | ☽ POST | $25.00 | $25.55 | $25.34 | 1,260,300 | -9.94% | open_in_new |
| Aug 12, 2025 | ☽ POST | $13.16 | $13.65 | $13.53 | 483,100 | +24.98% | open_in_new |
| May 13, 2025 | ☀ PRE | $10.44 | $10.44 | $8.93 | 881,900 | -7.56% | open_in_new |
| Mar 18, 2025 | ☀ PRE | $8.63 | $8.93 | $8.87 | 1,628,600 | -1.44% | open_in_new |
| Nov 05, 2024 | ☀ PRE | $13.09 | $13.09 | $13.05 | 383,700 | -0.38% | open_in_new |
| Aug 07, 2024 | ☀ PRE | $15.02 | $15.02 | $13.71 | 528,400 | -3.65% | open_in_new |
| May 06, 2024 | ☀ PRE | $12.02 | $12.31 | $11.87 | 609,000 | -1.25% | open_in_new |
| Mar 25, 2024 | ☽ POST | $6.29 | $6.80 | $6.50 | 2,566,700 | +58.31% | open_in_new |
| Nov 07, 2023 | ☀ PRE | $4.31 | $4.96 | $4.85 | 226,200 | +12.53% | open_in_new |
| Aug 07, 2023 | ☀ PRE | $5.61 | $5.97 | $5.85 | 558,700 | -4.41% | open_in_new |
| May 04, 2023 | ☀ PRE | $9.34 | $11.24 | $10.72 | 396,900 | +12.96% | open_in_new |
| Mar 06, 2023 | ☀ PRE | $8.90 | $9.24 | $9.24 | 127,400 | +4.64% | open_in_new |
| Nov 14, 2022 | ☀ PRE | $10.10 | $10.30 | $9.33 | 1,673,600 | -25.3% | open_in_new |
| Aug 08, 2022 | ☀ PRE | $17.00 | $22.17 | $21.16 | 393,100 | +26.03% | open_in_new |
| May 10, 2022 | ☀ PRE | $13.24 | $14.11 | $13.70 | 544,800 | +7.96% | open_in_new |
| Mar 10, 2022 | ☀ PRE | $20.67 | $20.78 | $20.59 | 105,000 | -0.91% | open_in_new |
| Nov 08, 2021 | ☀ PRE | $25.95 | $26.90 | $26.65 | 148,400 | +2.62% | open_in_new |
| Aug 10, 2021 | ☀ PRE | $25.50 | $27.28 | $25.94 | 126,200 | -1.56% | open_in_new |
| May 10, 2021 | ☀ PRE | $33.45 | $34.26 | $32.97 | 175,200 | +1.57% | open_in_new |
| Mar 09, 2021 | ☀ PRE | $51.78 | $57.00 | $51.88 | 297,300 | +2.77% | open_in_new |
| Nov 12, 2020 | ☀ PRE | $44.00 | $45.96 | $44.16 | 172,700 | -2.34% | open_in_new |
| Aug 10, 2020 | ☀ PRE | $27.00 | $28.40 | $28.19 | 139,300 | +5.15% | open_in_new |
| May 15, 2020 | ☀ PRE | $24.39 | $25.36 | $24.88 | 46,500 | +3.8% | open_in_new |
| Mar 23, 2020 | ☀ PRE | $22.66 | $22.66 | $19.62 | 403,000 | -11.66% | open_in_new |
| Nov 12, 2019 | ☀ PRE | $30.27 | $31.36 | $27.41 | 162,200 | -7.99% | open_in_new |
| Aug 14, 2019 | ☀ PRE | $28.13 | $31.59 | $30.27 | 71,700 | +0.9% | open_in_new |
Earnings Count
28
Total earnings in dataset
Avg Abs. Movement
±9.05%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 8-K | 20260604 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260518 | open_in_new SEC.gov |
Frequently asked about STOK earnings
When does Stoke Therapeutics, Inc. report earnings next? expand_more
Stoke Therapeutics, Inc. (STOK)'s next earnings date is approximate for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does STOK stock move after earnings? expand_more
Over 28 reports, STOK has moved an average of ±9.05% the session after earnings, closing higher 50.0% of the time.
What was STOK's biggest post-earnings move? expand_more
STOK's largest post-earnings gain on record was +58.31% on Mar 25, 2024, and its largest decline was -25.3% on Nov 14, 2022.
Where can I find Stoke Therapeutics, Inc.'s SEC filings? expand_more
All of Stoke Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right